JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 85 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21 | +425.0% | 12,300 | +200.0% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 4,100 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -25.0% | 4,100 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -55.6% | 4,100 | 0.0% | 0.00% | – |
| Q1 2022 | $27,000 | -20.6% | 4,100 | 0.0% | 0.00% | – |
| Q4 2021 | $34,000 | +13.3% | 4,100 | 0.0% | 0.00% | – |
| Q3 2021 | $30,000 | -63.4% | 4,100 | -66.4% | 0.00% | – |
| Q2 2021 | $82,000 | -34.4% | 12,200 | 0.0% | 0.00% | – |
| Q1 2021 | $125,000 | -39.6% | 12,200 | -58.8% | 0.00% | -100.0% |
| Q4 2020 | $207,000 | -47.5% | 29,600 | -38.8% | 0.00% | -50.0% |
| Q3 2020 | $394,000 | -19.6% | 48,400 | -31.9% | 0.00% | 0.0% |
| Q2 2020 | $490,000 | -2.2% | 71,100 | -32.7% | 0.00% | -33.3% |
| Q1 2020 | $501,000 | -15.5% | 105,600 | +55.3% | 0.00% | +50.0% |
| Q4 2019 | $593,000 | -42.4% | 68,000 | -78.0% | 0.00% | 0.0% |
| Q3 2019 | $1,030,000 | +119.1% | 309,600 | +225.6% | 0.00% | 0.0% |
| Q2 2019 | $470,000 | +8.0% | 95,100 | +387.7% | 0.00% | 0.0% |
| Q1 2018 | $435,000 | +23.2% | 19,500 | -29.6% | 0.00% | 0.0% |
| Q4 2017 | $353,000 | -45.1% | 27,700 | -32.9% | 0.00% | -33.3% |
| Q3 2017 | $643,000 | +22.9% | 41,300 | +10.7% | 0.00% | +50.0% |
| Q2 2017 | $523,000 | +1175.6% | 37,300 | +1863.2% | 0.00% | – |
| Q1 2017 | $41,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |